Neuphoria Therapeutics, Inc. (NEUP)
3.73
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
3.74
+0.01
(+0.27%)
After-Hours: 20:00
Neuphoria Therapeutics Market Cap : 20.06M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 20.06M |
| September 10, 2026 | 20.06M |
| September 09, 2026 | 20.16M |
| September 08, 2026 | 20.16M |
| September 04, 2026 | 20.27M |
| September 03, 2026 | 20.22M |
| September 02, 2026 | 20.16M |
| September 01, 2026 | 20.38M |
| August 31, 2026 | 20.22M |
| August 28, 2026 | 20.22M |
| August 27, 2026 | 20.27M |
| August 26, 2026 | 20.76M |
| August 25, 2026 | 20.76M |
| August 24, 2026 | 21.24M |
| August 21, 2026 | 21.03M |
| August 20, 2026 | 21.24M |
| August 19, 2026 | 21.13M |
| August 18, 2026 | 21.40M |
| August 17, 2026 | 20.70M |
| August 14, 2026 | 20.81M |
| August 13, 2026 | 20.60M |
| August 12, 2026 | 20.49M |
| August 11, 2026 | 20.49M |
| August 10, 2026 | 20.76M |
| August 07, 2026 | 20.54M |
| Date | Value |
|---|---|
| August 06, 2026 | 20.97M |
| August 05, 2026 | 21.24M |
| August 04, 2026 | 20.92M |
| August 03, 2026 | 21.13M |
| July 31, 2026 | 20.86M |
| July 30, 2026 | 21.08M |
| July 29, 2026 | 20.43M |
| July 28, 2026 | 20.49M |
| July 27, 2026 | 20.70M |
| July 24, 2026 | 19.57M |
| July 23, 2026 | 21.08M |
| July 22, 2026 | 17.91M |
| July 21, 2026 | 17.96M |
| July 20, 2026 | 17.75M |
| July 17, 2026 | 18.36M |
| July 16, 2026 | 18.98M |
| July 15, 2026 | 18.93M |
| July 14, 2026 | 19.20M |
| July 13, 2026 | 18.77M |
| July 10, 2026 | 19.04M |
| July 09, 2026 | 18.87M |
| July 08, 2026 | 18.93M |
| July 07, 2026 | 19.30M |
| July 06, 2026 | 18.50M |
| July 02, 2026 | 18.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 295.75M |
| Amgen, Inc. | 204.00B |
| Anika Therapeutics, Inc. | 279.17M |
| BioCryst Pharmaceuticals, Inc. | 2.073B |
| Imunon, Inc. | 6.859M |
Market Cap Related Metrics
| PE Ratio | 2.931 |
| PS Ratio | 0.8649 |
| Price to Book Value | 0.6817 |
| Price | 3.73 |
| Earnings Yield | 34.12% |
| Operating PE Ratio | 5.567 |
| Normalized PE Ratio | 1.593 |